Hangzhou Wensli Silk Culture
301066
Yoantion Industrial Inc.,
301053
Xinlei Compressor
301317
4
QIFENG
873169
5
LAISAI LASER
871263
CN Stock MarketDetailed Quotes
301201 Chengda Pharmaceuticals
- 21.30
- -0.85-3.84%
Market Closed May 9 15:00 CST
3.30BMarket Cap-68.49P/E (TTM)
25.19High21.18Low134.99KlotVolume24.40Open22.15Pre Close310.38MTurnover15.48%Turnover RatioLossP/E (Static)154.71MShares26.5252wk High1.54P/B1.86BFloat Cap16.5052wk Low26.58Limit Up87.19MShs Float116.84Historical High17.72Limit Down18.10%Amplitude14.40Historical Low0.20Dividend TTM22.99Avg Price70.99KlotAsk0.94%Div YieldTTM100Lot Size55.62KlotBid
Chengda Pharmaceuticals Key Stats
All
YOY
| (Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -24.37%76.31M | -19.59%333.13M | -6.34%243.77M | -1.55%164.01M | -1.28%100.89M | 0.69%414.3M | -14.85%260.26M | -23.31%166.59M | -5.91%102.2M | -1.03%411.46M |
| Operating revenue | -24.37%76.31M | -19.59%333.13M | -6.34%243.77M | -1.55%164.01M | -1.28%100.89M | 0.69%414.3M | -14.85%260.26M | -23.31%166.59M | -5.91%102.2M | -1.03%411.46M |
| Other operating revenue | ---- | 122.65%2.28M | ---- | 89.80%852.87K | ---- | 727.26%1.03M | ---- | --449.36K | ---- | -10.70%124K |
| Total operating cost | -9.37%80.61M | 11.83%393.07M | 4.78%235.4M | 9.47%164.25M | 0.46%88.95M | 7.88%351.49M | -2.84%224.67M | -4.81%150.04M | 11.52%88.54M | 7.24%325.83M |
| Operating cost | -33.65%39.63M | -19.50%190.48M | -9.88%137.62M | -2.79%99.64M | -8.02%59.73M | 10.61%236.62M | 1.24%152.7M | -4.00%102.5M | 23.53%64.94M | 2.86%213.93M |
| Operating tax surcharges | 0.34%424.56K | 19.84%4.28M | 38.21%2.27M | 116.63%2.17M | -13.21%423.12K | -13.98%3.57M | -25.59%1.65M | -8.27%1M | 129.85%487.51K | 67.98%4.15M |
| Operating expense | -9.66%846.36K | 45.05%4.63M | 29.06%3.34M | 30.90%2.18M | -7.09%936.91K | -40.85%3.2M | -29.93%2.59M | -38.53%1.66M | -39.18%1.01M | 19.77%5.4M |
| Administration expense | 62.43%30.81M | 17.71%104M | 13.34%65.62M | 20.40%44.12M | 10.12%18.97M | 0.05%88.36M | -11.71%57.9M | -11.15%36.65M | -15.00%17.22M | 28.15%88.31M |
| Financial expense | 86.78%-117.59K | 47.68%-4.04M | 46.64%-3.23M | -102.29%-2.97M | -787.18%-889.35K | -42.76%-7.72M | -6.01%-6.05M | 60.84%-1.47M | 145.92%129.42K | -297.80%-5.41M |
| -Interest expense (Financial expense) | 5,911.84%605.06K | --295.34K | ---- | --12.36K | -37.21%10.06K | ---- | ---- | ---- | -91.86%16.03K | -85.81%198.48K |
| -Interest Income (Financial expense) | 37.47%-485.62K | 68.19%-2.03M | 62.54%-1.67M | -1,047.83%-1.21M | -1,386.70%-776.61K | -545.82%-6.37M | -334.61%-4.45M | 89.57%-105.63K | 94.01%-52.24K | -284.99%-986.61K |
| Research and development | -7.77%9.02M | 241.20%93.71M | 87.35%29.78M | 97.03%19.11M | 105.63%9.78M | 41.26%27.46M | 8.68%15.9M | 1.57%9.7M | -4.46%4.76M | 12.89%19.44M |
| Credit Impairment Loss | -279.81%-1.85M | 178.93%4.76M | 161.21%5.98M | 110.39%4.45M | 711.93%1.03M | -438.25%-6.03M | 2,529.50%2.29M | 5,353.89%2.11M | 131.61%126.74K | 22.10%-1.12M |
| Asset Impairment Loss | 25.85%-607K | -314.54%-7.84M | -312.56%-3.63M | 20.27%-1.12M | -130.77%-818.66K | 141.02%3.66M | 444.17%1.71M | -6,286.04%-1.4M | 1,997.57%2.66M | -688.20%-8.91M |
| Other net revenue | -74.20%2.85M | -21.38%35.37M | -1.38%36.34M | 42.89%27.83M | 7.47%11.04M | 16.52%44.99M | 3.88%36.85M | -8.78%19.48M | 500.52%10.27M | 595.82%38.61M |
| Fair value change income | --477.76K | --1.6M | --4.97M | --3.66M | ---- | ---- | ---- | ---- | ---- | --393.37K |
| Invest income | -55.90%4.12M | -26.39%30.79M | -19.08%23.82M | 14.12%18.83M | 33.83%9.34M | 6.51%41.82M | 219.83%29.43M | 217.26%16.5M | 735.17%6.98M | --39.27M |
| Asset deal income | -62.46%34.49K | 6,168.38%204.74K | 6,168.38%204.74K | 3,863.35%129.45K | 2,712.87%91.87K | 100.61%3.27K | 100.61%3.27K | 100.61%3.27K | 100.61%3.27K | -2,487.86%-531.11K |
| Other revenue | -51.83%675.01K | 5.95%5.86M | 46.32%4.99M | -17.03%1.87M | 177.00%1.4M | -41.83%5.53M | -61.88%3.41M | -70.95%2.26M | -74.12%505.91K | 16.91%9.51M |
| Operating profit | -106.33%-1.46M | -122.79%-24.57M | -38.28%44.7M | -23.41%27.59M | -3.95%22.98M | -13.24%107.8M | -34.09%72.43M | -55.51%36.02M | -22.64%23.93M | 5.79%124.25M |
| Add:Non operating Income | -73.78%625.47 | -38.79%60.87K | -80.87%11.71K | -79.31%6.16K | -83.87%2.39K | 92.76%99.43K | 131.58%61.24K | 155.85%29.79K | 121.64%14.79K | -89.01%51.58K |
| Less:Non operating expense | -91.54%80.31K | -26.70%2.67M | -27.44%2.28M | -56.04%1.34M | 11.82%948.95K | -12.90%3.65M | 88.55%3.14M | 209.50%3.04M | 808.78%848.61K | 59.48%4.19M |
| Total profit | -106.97%-1.54M | -126.07%-27.18M | -38.81%42.44M | -20.45%26.26M | -4.58%22.04M | -13.20%104.25M | -35.93%69.35M | -58.74%33.01M | -25.12%23.1M | 4.18%120.11M |
| Less:Income tax cost | -106.13%-203.1K | -96.53%456.1K | -76.46%1.9M | -70.80%1.05M | -4.74%3.31M | -3.55%13.15M | -50.33%8.07M | -75.94%3.59M | -24.97%3.48M | -9.19%13.63M |
| Net profit | -107.12%-1.33M | -130.34%-27.64M | -33.85%40.54M | -14.30%25.21M | -4.56%18.73M | -14.44%91.1M | -33.39%61.28M | -54.79%29.41M | -25.15%19.62M | 6.19%106.48M |
| Net profit from continuing operation | -107.12%-1.33M | -130.34%-27.64M | -33.85%40.54M | -14.30%25.21M | -4.56%18.73M | -14.44%91.1M | -33.39%61.28M | -54.79%29.41M | -25.15%19.62M | 6.19%106.48M |
| Less:Minority Profit | -17.58%67.4K | 281.68%464.5K | 57.73%143.48K | -47.20%33.03K | 431.38%81.78K | 1,806.32%121.7K | 259.26%90.96K | 288.36%62.56K | -46.54%-24.68K | 95.59%-7.13K |
| Net profit of parent company owners | -107.51%-1.4M | -130.89%-28.1M | -33.98%40.39M | -14.23%25.17M | -5.09%18.64M | -14.56%90.98M | -33.53%61.18M | -54.91%29.35M | -25.10%19.64M | 6.02%106.48M |
| Earning per share | ||||||||||
| Basic earning per share | -107.57%-0.0092 | -131.44%-0.1849 | -32.90%0.2654 | -13.02%0.165 | -4.33%0.1215 | -16.33%0.5881 | -35.37%0.3955 | -72.99%0.1897 | -57.08%0.127 | -49.25%0.7029 |
| Diluted earning per share | -107.57%-0.0092 | -131.44%-0.1849 | -32.90%0.2654 | -13.02%0.165 | -4.33%0.1215 | -16.33%0.5881 | -35.37%0.3955 | -72.99%0.1897 | -57.08%0.127 | -49.25%0.7029 |
| Other composite income | -19.2M | |||||||||
| Other composite income of parent company owners | ---- | ---19.2M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Total composite income | -107.12%-1.33M | -151.42%-46.84M | -33.85%40.54M | -14.30%25.21M | -4.56%18.73M | -14.44%91.1M | -33.39%61.28M | -54.79%29.41M | -25.15%19.62M | 6.19%106.48M |
| Total composite income of parent company owners | -107.51%-1.4M | -151.99%-47.31M | -33.98%40.39M | -14.23%25.17M | -5.09%18.64M | -14.56%90.98M | -33.53%61.18M | -54.91%29.35M | -25.10%19.64M | 6.02%106.48M |
| Total composite income of minority owners | -17.58%67.4K | 281.68%464.5K | 57.73%143.48K | -47.20%33.03K | 431.38%81.78K | 1,806.32%121.7K | 259.26%90.96K | 288.36%62.56K | -46.54%-24.68K | 95.59%-7.13K |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | Zhonghua Certified Public Accountants (Special General Partnership) | -- | -- | -- | Zhonghua Certified Public Accountants (Special General Partnership) | -- | -- | -- | Zhonghua Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.